- Home
- EXEL vs HAS Comparison
EXEL vs HAS Comparison
Compare EXEL & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- HAS
- Stock Information
- Founded
- EXEL 1994
- HAS 1923
- Country
- EXEL United States
- HAS United States
- Employees
- EXEL N/A
- HAS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- HAS Recreational Games/Products/Toys
- Sector
- EXEL Health Care
- HAS Consumer Discretionary
- Exchange
- EXEL Nasdaq
- HAS Nasdaq
- Market Cap
- EXEL 9.7B
- HAS 8.7B
- IPO Year
- EXEL 2000
- HAS N/A
- Fundamental
- Price
- EXEL $34.45
- HAS $62.21
- Analyst Decision
- EXEL Buy
- HAS Strong Buy
- Analyst Count
- EXEL 18
- HAS 9
- Target Price
- EXEL $31.72
- HAS $78.00
- AVG Volume (30 Days)
- EXEL 2.6M
- HAS 1.6M
- Earning Date
- EXEL 10-29-2024
- HAS 10-24-2024
- Dividend Yield
- EXEL N/A
- HAS 4.50%
- EPS Growth
- EXEL 441.02
- HAS N/A
- EPS
- EXEL 1.55
- HAS N/A
- Revenue
- EXEL $2,081,598,000.00
- HAS $4,322,800,000.00
- Revenue This Year
- EXEL $20.53
- HAS N/A
- Revenue Next Year
- EXEL $1.54
- HAS $4.68
- P/E Ratio
- EXEL $22.26
- HAS N/A
- Revenue Growth
- EXEL 17.31
- HAS N/A
- 52 Week Low
- EXEL $19.20
- HAS $43.74
- 52 Week High
- EXEL $36.60
- HAS $73.46
- Technical
- Relative Strength Index (RSI)
- EXEL 67.10
- HAS 28.81
- Support Level
- EXEL $27.86
- HAS $62.62
- Resistance Level
- EXEL $36.49
- HAS $64.40
- Average True Range (ATR)
- EXEL 0.98
- HAS 1.53
- MACD
- EXEL -0.01
- HAS -0.28
- Stochastic Oscillator
- EXEL 74.10
- HAS 1.25
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and production capabilities has helped bolster Hasbro's multichannel presence. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has pruned noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.